Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO

By: |
October 06, 2021 10:28 PM

Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella, had said on September 21 that the Paediatric Covaxin completed phase 2/3 trials with about 1,000 subjects and the data analysis was  going on.

covaxinAs part of the Phase II/III trial, the two-dose Covaxin was administered with 28 days apart.

Bharat Biotech, which completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age, has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation for the jab, company sources said on Wednesday.

“Covaxin clinical trial data of 2-18 years age group has been submitted to CDSCO…This is feasible due to the safety of the manufacturing platform and empirical evidence from Phase 1,2 and 3 clinical trials in adults,” sources told PTI.

Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella, had said on September 21 that the Paediatric Covaxin completed phase 2/3 trials with about 1,000 subjects and the data analysis was  going on.

As part of the Phase II/III trial, the two-dose Covaxin was administered with 28 days apart.

“We will be submitting the data (to the regulator) by next week,” he had said.

He also had said that Phase 2 trials of intranasal vaccine to prevent COVID-19 were going on and expected to be over in October.

If approved, Covaxin will be the first COVID-19 vaccine that can be administered to children in India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: Active cases drop to 74,735 in Kerala; 6,664 new cases, 281 deaths
2China to start vaccinating children to age 3 as cases spread
3Dengue cases in Delhi cross 1,000-mark; over 280 fresh cases in one week